Aptevo Therapeutics Inc. — All Filings
692 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DEFR14A
DFAN14A
DRS
EFFECT
PRE 14A
PREC14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001193125-26-126278 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-126190 | Mar 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-100539 | Mar 11, 2026 | Mar 10, 2026 |
| 8-K | 8-K | 0001193125-26-057707 | Feb 19, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | — | 0000902664-26-001127 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001649553-26-000020 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-034473 | Feb 3, 2026 | Jan 30, 2026 |
| EFFECT | — | 9999999995-26-000430 | Jan 30, 2026 | — |
| 424B4 | 424B4 | 0001193125-26-032011 | Jan 30, 2026 | — |
| S-1 | S-1 | 0001193125-26-027200 | Jan 28, 2026 | — |
| DEF 14A | DEF 14A | 0001193125-26-022560 | Jan 26, 2026 | Jan 23, 2026 |
| PRE 14A | PRE 14A | 0001193125-26-015339 | Jan 16, 2026 | — |
| 8-K | 8-K | 0001193125-26-008318 | Jan 9, 2026 | Jan 8, 2026 |
| 8-K | 8-K | 0001193125-25-335497 | Dec 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-312972 | Dec 9, 2025 | — |
| EFFECT | — | 9999999995-25-003381 | Nov 25, 2025 | — |
| 424B4 | 424B4 | 0001193125-25-297513 | Nov 25, 2025 | — |
| 4 | 4 | 0001193125-25-277771 | Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | 10-Q | 0001193125-25-269598 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269470 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-258665 | Oct 30, 2025 | — |
| S-1 | S-1 | 0001193125-25-226825 | Oct 1, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-004113 | Sep 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-205107 | Sep 16, 2025 | — |
| 8-K | 8-K | 0001671584-25-000005 | Sep 4, 2025 | — |
| SCHEDULE 13G/A | — | 0001079973-25-001313 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000151 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0001641172-25-023309 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106247 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-106246 | Aug 11, 2025 | — |
| 4 | 4 | 0000950170-25-105942 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105938 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105936 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105935 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105933 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105930 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105922 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105919 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105894 | Aug 8, 2025 | Aug 6, 2025 |
| 4 | 4 | 0000950170-25-105887 | Aug 8, 2025 | Aug 6, 2025 |
| 424B4 | 424B4 | 0000950170-25-105823 | Aug 8, 2025 | — |
| EFFECT | — | 9999999995-25-002457 | Aug 1, 2025 | — |
| CORRESP | — | 0000950170-25-100776 | Jul 31, 2025 | — |
| UPLOAD | — | 0000000000-25-008051 | Jul 30, 2025 | — |
| S-1 | S-1 | 0000950170-25-098788 | Jul 25, 2025 | — |
| 8-K | 8-K | 0000950170-25-098429 | Jul 24, 2025 | — |
| 4 | 4 | 0000950170-25-097283 | Jul 21, 2025 | Jul 17, 2025 |
| 4 | 4 | 0000950170-25-097280 | Jul 21, 2025 | Jul 17, 2025 |
| 4 | 4 | 0000950170-25-097279 | Jul 21, 2025 | Jul 17, 2025 |
| 4 | 4 | 0000950170-25-097278 | Jul 21, 2025 | Jul 17, 2025 |